Group 1 - The company will hold a performance briefing for the fiscal year 2024 and the first quarter of 2025 on June 6, 2025, from 10:00 to 11:00 [1][2] - The briefing will be conducted in an interactive online format via the Shanghai Stock Exchange Roadshow Center [2][3] - Key personnel attending the meeting include the Chairman, General Manager, Board Secretary, Financial Director, and Independent Director [2] Group 2 - Investors can submit questions for the briefing from May 29, 2025, to June 5, 2025, by logging into the Shanghai Stock Exchange Roadshow Center or via the company's email [2][3] - Contact information for inquiries includes a designated contact person and a phone number [3] - After the briefing, investors can access the meeting's main content and updates through the Shanghai Stock Exchange Roadshow Center [3]

| 股票简称：新化股份 | 股票代码：603867 | 公告编号：2025-029 | | --- | --- | --- | | 转债简称：新化转债 | 转债代码：113663 | | 公告 浙江新化化工股份有限公司（以下简称"公司"）已于2025年4月29日发布 公司2024年度报告及2025年第一季度报告，为便于广大投资者更全面深入地了解 公司2024年度及2025年第一季度经营成果、财务状况，公司计划于2025年06月06 日 （星期五） 10:00-11:00举行2024年度暨2025年第一季度业绩说明会，就投 资者关心的问题进行交流。 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性承担个别及连带责任。 重要内容提示： 会议召开时间：2025年06月06日 （星期五） 10:00-11:00 会议召开地点：上海证券交易所上证路演中心（网址：https://roadshow.s seinfo.com/） 会议召开方式：上证路演中心网络互动 投资者可于2025年05月29日 （星期四） 至06月05日 （星期四）16:00前登 录上证 ...

Core Viewpoint - Zhejiang Xinhua Chemical Co., Ltd. has announced the closure of its special account for the funds raised from the issuance of convertible bonds, following the completion of the relevant investment projects and the decision to permanently supplement the remaining funds into working capital [1][2]. Fundraising Overview - The company issued 6,500,000 convertible bonds at a face value of RMB 100 each, raising a total of RMB 65 million. The net amount after deducting underwriting and related fees was RMB 63.93 million [1]. - The funds were managed in a dedicated account, with a tripartite supervision agreement established with the underwriter and the bank [2]. Fund Management Situation - The company adhered to regulatory requirements for the management and use of raised funds, ensuring that the funds were stored in a dedicated account and that all parties' rights and obligations were clearly defined [2]. - The company has completed the necessary procedures for the closure of the fundraising account, and the related supervision agreements have been terminated [4].

| 股票简称：新化股份 | 股票代码：603867 | 公告编号：2025-028 | | --- | --- | --- | | 转债简称：新化转债 | 转债代码：113663 | | 浙江新化化工股份有限公司 根据中国证券监督管理委员会《关于核准浙江新化化工股份有限公司公开发 行可转换公司债券的批复》（证监许可〔2022〕2163号），公司由主承销商东方 证券承销保荐有限公司负责发行组织实施。实际发行可转换公司债券6,500,000 张，每张面值为人民币100.00元，按面值发行，发行总额为人民币65,000.00万 元。其中，向公司原股东优先配售49,778.60万元，通过网上向社会公众投资者 发行14,969.20万元，由主承销商包销252.20万元，共计募集资金65,000.00万元， 扣除承销和保荐费用848万元（含税）后的募集资金为64,152万元，已由主承销 商东方证券承销保荐有限公司于2022年12月2日汇入本公司募集资金监管账户。 减除律师费、审计及验资费、资信评级费、信息披露费、材料制作费及发行手续 费等与发行可转换公司债券直接相关的新增外部费用274.67万元（不含税），增 加承销及保 ...

| 证券代码：603867 | 证券简称：新化股份 | 公告编号：2025-026 | | --- | --- | --- | | 转债代码：113663 | 转债简称：新化转债 | | 浙江新化化工股份有限公司 第六届董事会第十七次会议决议公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性承担个别及连带责任。 一、董事会会议召开情况 浙江新化化工股份有限公司（以下简称"公司"）第六届董事会第十七次会 议（以下简称"本次会议"）于 2025 年 5 月 20 日以现场结合通讯会议方式召开。 本次会议应参会董事 9 名，实际参会董事 8 名，职工董事方军伟先生因公务未能 出席本次会议，会议由董事长应思斌先生主持，本次会议的召开符合《中华人民 共和国公司法》和《公司章程》的规定。 表决结果：同意 8 票，反对 0 票，弃权 0 票。 3、审议通过《关于补选专门委员会委员的议案》 二、董事会会议审议情况 1、审议通过《关于聘任公司副总经理的议案》 经公司总经理提名，董事会提名委员会审核通过，董事会聘任赵建标先生为 公司副总经理，任期与本届董事会 ...

Core Viewpoint - The document outlines the information disclosure deferral and exemption management system for Zhejiang Xinhua Chemical Co., Ltd, ensuring compliance with relevant laws and regulations while protecting sensitive information [1][2][3]. Group 1: General Principles - The system is established to regulate the deferral and exemption of information disclosure, ensuring that the company and related parties fulfill their disclosure obligations in accordance with the law [1]. - Information disclosure obligations can be deferred or exempted based on specific circumstances as defined by the Stock Listing Rules without prior application to the Shanghai Stock Exchange [1][2]. Group 2: Scope of Deferral and Exemption - Information that involves state secrets or could violate confidentiality regulations may be exempted from disclosure if sufficient evidence is provided [2]. - Disclosure of commercial secrets can be deferred or exempted if it could lead to unfair competition or harm the interests of the company or its stakeholders [2][3]. Group 3: Internal Management of Disclosure - The company must carefully determine the need for deferral or exemption and implement measures to prevent the leakage of such information [4]. - Information that is deferred or exempted must be accurately reported and documented, ensuring that the number of individuals aware of the information is minimized [4][5]. Group 4: Approval Process - A formal approval process is required for deferring or exempting disclosure, including documentation and internal review by the board secretary and chairman [5][6]. - If the reasons for deferral or exemption are no longer valid, the company must promptly disclose the information and the rationale for its previous status [6][7]. Group 5: Accountability - The company reserves the right to hold individuals accountable for any violations of the disclosure management system or related regulations [7].

Group 1 - The sixth board meeting of Zhejiang Xinhua Chemical Co., Ltd. was held on May 20, 2025, combining on-site and telecommunication methods [1] - Eight out of nine directors attended the meeting, with one director absent due to official duties [1] - The board approved the appointment of Mr. Zhao Jianbiao as the vice general manager, with a term consistent with the current board [1] Group 2 - The voting results for the appointment were unanimous, with 8 votes in favor, 0 against, and 0 abstentions [2] - The proposal was also reviewed and approved by the independent directors in their second meeting of 2025 [2] - The voting results from the independent directors' meeting showed 6 votes in favor, 0 against, and 0 abstentions, with related directors abstaining from the vote [2]

Group 1 - The company plans to transfer 24.5% of its subsidiary's shares in a consulting firm to enhance competitiveness and attract new resources [1][2] - 17% of the shares will be sold to the company's chairman, Mr. Ying Sibin, for a total price of 2,759,429.88 RMB [1][4] - The transaction has been approved by the company's board and does not require shareholder approval [2][4] Group 2 - The purpose of the transaction is to motivate core employees and expand the application of lithium-related technologies [2][4] - The consulting firm, Jian De Shi Jia Ma Management Consulting Partnership, has a registered capital of 3 million RMB and focuses on management consulting and technical services [2][3] - The financial information indicates that the consulting firm had total assets of 16,231,940.49 RMB as of December 31, 2024, with no liabilities [3][4] Group 3 - The transaction price is based on the net asset value of the consulting firm as of December 31, 2024, ensuring fairness and reasonableness [4] - The transaction amount represents only 0.11% of the company's latest audited net assets, indicating minimal impact on financial status [4] - The board's independent directors reviewed and approved the transaction in a dedicated meeting [2][4]

浙江新化化工股份有限公司 信息披露暂缓与豁免业务管理制度 第一章 总 则 第一条 为规范浙江新化化工股份有限公司（以下简称"公司"）信息披露 暂缓与豁免行为，保证公司及相关信息披露义务人（以下简称"信息披露义务人"） 依法合规履行信息披露义务，根据《中华人民共和国公司法》、《中华人民共和 国证券法》、《上海证券交易所股票上市规则》（以下简称"《股票上市规则》"）、 《上海证券交易所上市公司自律监管指引第 2 号——信息披露事务管理》等法律、 法规、规范性文件的相关规定以及《浙江新化化工股份有限公司章程》和《浙江 新化化工股份有限公司信息披露管理制度》等有关规定，制定本制度。 第二条 信息披露义务人按照《股票上市规则》及上海证券交易所其他相关 业务规则的规定，办理信息披露暂缓、豁免业务的，适用本制度。 第六条 公司和其他信息披露义务人拟披露的信息涉及商业秘密或者保密商 务信息（以下统称"商业秘密"），符合下列情形之一，且尚未公开或者泄露的， 可以暂缓或者豁免披露： （一）属于核心技术信息等，披露后可能引致不正当竞争的； （二）属于公司自身经营信息，客户、供应商等他人经营信息，披露后可能 侵犯公司、他人商业秘密或 ...